Table I. Common pathways towards the development of more effective pharmacologic strategies for Major Depressive Disorder (MDD).
• Develop new agents as monotherapy |
• Combine two or more pharmacologic treatments
|
• Identify subpopulations of MDD patients who are more likely to experience the benefits of a given treatment
|